Covered recipient · General Payments record
KEITH S LEIBOWITZ
Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease
General Payments · PY2019–2025
$2,688.46
- Reported across 155 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $562.42 | 31 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $159.90 | 10 |
| Amgen Inc. | $96.30 | 6 |
| Novo Nordisk AS | $56.49 | 3 |
| Philips Electronics North America Corporation | $44.81 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $41.65 | 2 |
| CVRx Inc. | $40.00 | 2 |
| Esperion Therapeutics, Inc. | $31.16 | 2 |
| BAXTER HEALTHCARE | $25.50 | 1 |
| BridgeBio Pharma, Inc. | $19.00 | 1 |
| GlaxoSmithKline, LLC. | $18.85 | 1 |
| E.R. Squibb & Sons, L.L.C. | $14.42 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $14.34 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (31)
Sorted by paying entity, then date · as published by CMS
Program year 2025 201920202021202220232024
Record-level detail is published for PY2025; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $16.42 | 01/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228536577 | CMS |
| Amgen Inc. | $16.00 | 04/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228536575 | CMS |
| Amgen Inc. | $14.22 | 06/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227072430 | CMS |
| Amgen Inc. | $17.68 | 08/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228536581 | CMS |
| Amgen Inc. | $15.99 | 09/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228536579 | CMS |
| Amgen Inc. | $15.99 | 12/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228536583 | CMS |
| Baxter Healthcare | $25.50 | 02/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1181560272 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $20.90 | 10/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1225623164 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $20.75 | 11/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1225623166 | CMS |
| BridgeBio Pharma, Inc. | $19.00 | 08/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1250432517 | CMS |
| CVRx, Inc. | $20.00 | 01/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1218107220 | CMS |
| CVRx, Inc. | $20.00 | 01/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1218109995 | CMS |
| E.R. Squibb & Sons, L.L.C. | $14.42 | 03/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1184558068 | CMS |
| Esperion Therapeutics, Inc. | $17.00 | 03/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1243965826 | CMS |
| Esperion Therapeutics, Inc. | $14.16 | 06/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1243965828 | CMS |
| GlaxoSmithKline, LLC. | $18.85 | 09/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1190997884 | CMS |
| Novartis Pharmaceuticals Corporation | $14.34 | 02/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1200691262 | CMS |
| Novo Nordisk Inc | $18.98 | 05/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188851272 | CMS |
| Novo Nordisk Inc | $18.97 | 07/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188412097 | CMS |
| Novo Nordisk Inc | $18.54 | 10/02/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188505761 | CMS |
| PFIZER INC. | $16.53 | 01/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1231207939 | CMS |
| PFIZER INC. | $17.57 | 03/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1231464777 | CMS |
| PFIZER INC. | $16.03 | 03/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1231261972 | CMS |
| PFIZER INC. | $12.23 | 05/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1231296193 | CMS |
| PFIZER INC. | $17.72 | 06/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228822548 | CMS |
| PFIZER INC. | $14.51 | 07/02/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1231706169 | CMS |
| PFIZER INC. | $17.57 | 10/02/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1229983660 | CMS |
| PFIZER INC. | $15.50 | 10/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1229408892 | CMS |
| PFIZER INC. | $15.40 | 11/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1229581608 | CMS |
| PFIZER INC. | $16.84 | 11/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1229613368 | CMS |
| Philips North America LLC | $44.81 | 05/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1232631757 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.